/Companies

SI-BONE

NASDAQ: SIBN

San Jose, US · Delaware corporation · 3 known investors

Find your way into SI-BONE

Each arrow is one introduction. Sign up to fill in the first one.

21 people can intro you to Mark

Ask Tim Petersen to introduce you to Mark Reiley

You →Tim · together at SI-BONE →Mark

Sign up to find every way you can get introduced to SI-BONE

  • Your email: who you already know at SI-BONE, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the SI-BONE team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

SI-BONE develops medical devices for treating sacroiliac (SI) joint dysfunction and chronic low back pain, targeting patients and physicians. Its main offering is a minimally invasive implant system used for SI joint fusion surgery.

Founders & leadership

MR
Mark ReileyFounderMark Reiley founded and served as inventor for multiple medical device and pharmaceutical companies including Kyphon, Archus, Inbone Technologies, Reiley Orthopedics, SI-BONE, Fixes 4 Kids, and Reiley Pharmaceuticals.
JWJeffrey W. Dunn
Jeffrey W. DunnExecutive
RE
Robert E. JohnsonExecutive
DM
Dan MurrayExecutive
LALaura A. Francis
Laura A. FrancisChief Executive Officer

Board

TE
Timothy E. DavisBoard director
JG
John G. FreundBoard director
DBDavid Bonita
David BonitaBoard directorGeneral Partner at OrbiMed
KA
Karen A. LicitraBoard director
KC
Keith C. ValentineBoard director
GK
Gregory K. HinckleyBoard director
JS
John SavareseBoard directorGeneral Partner at Montreux Equity Partners

Investors · 3

Reported raises · per SEC filings

Form D private placements

$20M disclosed across 1 of 2 rounds · 2014–2016

▶$20MraisedJun 2016 · 9 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey W. DunnExecutive Officer, Director
  • Mark ReileyDirector
  • Timothy E. DavisDirector
  • John G. FreundDirector
  • David BonitaDirector
  • Karen A. LicitraDirector
  • Laura FrancisExecutive Officer
  • Robert E. JohnsonExecutive Officer
  • Keith C. ValentineDirector
  • Gregory K. HinckleyDirector
Offering amount
$21M
Amount sold
$20M
First sale
Jun 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$33MofferedMay 2014 · 13 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey DunnExecutive Officer, Director
  • Greg HinckleyDirector
  • John FreundDirector
  • John SavareseDirector
  • Ted DavisDirector
  • Dan MurrayExecutive Officer
  • Mark A. ReileyDirector
Offering amount
$33M
First sale
Apr 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events
$344.9Mvaluation at IPOOct 2018 · $15.00/share · 424B4
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

In the news

Frequently asked questions

What does SI-BONE do?
SI-BONE develops medical devices for treating sacroiliac (SI) joint dysfunction and chronic low back pain, targeting patients and physicians. Its main offering is a minimally invasive implant system used for SI joint fusion surgery.
Who founded SI-BONE?
SI-BONE was founded by Mark Reiley.
Who are SI-BONE's investors?
SI-BONE's investors include Arboretum Ventures, Montreux Equity Partners, OrbiMed.
How much funding has SI-BONE raised?
SI-BONE has disclosed $20M raised across 1 of its 2 known rounds.
Where is SI-BONE headquartered?
SI-BONE is headquartered in San Jose, US.